ONKURE THERAPEUTICS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -27.0% | -27.0% | -25.8% |
| FY2022 | 95.5% | 95.5% | -48.0% |
| FY2023 | 34.7% | 34.7% | -98.8% |
| FY2024 | -50.7% | -50.7% | -45.8% |
| FY2025 | -105.9% | -105.9% | -95.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -27.0% | -27.0% | -25.8% |
| FY2022 | 95.5% | 95.5% | -48.0% |
| FY2023 | 34.7% | 34.7% | -98.8% |
| FY2024 | -50.7% | -50.7% | -45.8% |
| FY2025 | -105.9% | -105.9% | -95.8% |